Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020092887 - ADIPOCYTE MEDIATED DELIVERY OF ANTICANCER THERAPEUTICS

Publication Number WO/2020/092887
Publication Date 07.05.2020
International Application No. PCT/US2019/059370
International Filing Date 01.11.2019
IPC
A61K 47/64 2017.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
50the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
51the non-active ingredient being a modifying agent
62the modifying agent being a protein, peptide or polyamino acid
64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
Applicants
  • NORTH CAROLINA STATE UNIVERSITY [US]/[US]
Inventors
  • GU, Zhen
  • WEN, Di
  • ZHANG, Xudong
Agents
  • LANIER, J. Gibson
  • HALL, Miles E.
  • CURFMAN, Christopher L.
Priority Data
62/754,28001.11.2018US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) ADIPOCYTE MEDIATED DELIVERY OF ANTICANCER THERAPEUTICS
(FR) APPORT D'AGENTS THÉRAPEUTIQUES ANTICANCÉREUX MÉDIÉ PAR DES ADIPOCYTES
Abstract
(EN)
Disclosed are compositions and methods related to the use of adipocytes for sustained release of anti-cancer therapeutics and treatment of cancer.
(FR)
L'invention concerne des compositions et des méthodes se rapportant à l'utilisation d'adipocytes pour la libération prolongée d'agents thérapeutiques anticancéreux et le traitement du cancer.
Latest bibliographic data on file with the International Bureau